Modified platelet rich plasma therapy for alopecia totalis.
Study Design
- Studientyp
- Case Reports
- Stichprobengröße
- 1
- Population
- Single patient with alopecia totalis
- Intervention
- Modified platelet rich plasma therapy for alopecia totalis. PRP + intralesional triamcinolone acetonide
- Vergleichsgruppe
- None
- Primärer Endpunkt
- Hair regrowth in alopecia totalis
- Wirkungsrichtung
- Positive
- Verzerrungsrisiko
- High
Abstract
Alopecia areata (AA) is an autoimmune disease characterized most commonly by patchy nonscarring hair loss which may progress to alopecia totalis which has poor prognosis. Platelet-rich plasma (PRP) therapy along with intralesional triamcinolone acetonide that is modified PRP proved to be beneficial in the case of alopecia totalis and helps in weaning patient off oral immunosuppression.
Zusammenfassung
Platelet-rich plasma (PRP) therapy along with intralesional triamcinolone acetonide that is modified PRP proved to be beneficial in the case of alopecia totalis and helps in weaning patient off oral immunosuppression.
Used In Evidence Reviews
Similar Papers
Journal of cosmetic dermatology · 2021
Treatment options for androgenetic alopecia: Efficacy, side effects, compliance, financial considerations, and ethics.
Stem cells translational medicine · 2015
The Effect of Platelet-Rich Plasma in Hair Regrowth: A Randomized Placebo-Controlled Trial.
Clinical reviews in allergy & immunology · 2021
Alopecia Areata: an Update on Etiopathogenesis, Diagnosis, and Management.
Cells · 2019
Advances in Regenerative Stem Cell Therapy in Androgenic Alopecia and Hair Loss: Wnt pathway, Growth-Factor, and Mesenchymal Stem Cell Signaling Impact Analysis on Cell Growth and Hair Follicle Development.
The British journal of dermatology · 2013
A randomized, double-blind, placebo- and active-controlled, half-head study to evaluate the effects of platelet-rich plasma on alopecia areata.
Journal of the European Academy of Dermatology and Venereology : JEADV · 2018